2005 Releases

Study Adds to Evidence of Immune Responses to Cancer: Dec-06-2005 — Results of a large study published in Proceedings of the National Academy of Sciences provide further evidence for the role of the immune system in controlling cancer.
Roswell Park Presents Novel Research at National Hematology Meeting: Dec-01-2005 — Asher A. Chanan, MD, Department of Medicine at Roswell Park Cancer Institute, will present novel research on multiple myeloma (MM) at the 47th Annual Meeting of the American Society of Hematology, December 10-13, Atlanta, GA.
Roswell Park Preliminary Studies Suggest Effective Therapies Against Chronic Lymphocytic Leukemia: Dec-01-2005 — Scientists from the laboratory of Asher A. Chanan-Khan, MD, Department of Medicine, RPCI, will present preliminary laboratory and clinical results of new therapies for chronic lymphocytic leukemia (CLL) at the 47th Annual Meeting of the American Society of Hematology, December 10-13, Atlanta, GA.
RPCI Investigators Present Promising Research for Non-Hodgkins Lymphoma at Hematology Meeting: Dec-01-2005 — Scientists from the Translational Lymphoma Research Laboratory of Myron S. Czuczman, MD, Departments of Medicine and Immunology at Roswell Park Cancer Institute (RPCI), will present preliminary laboratory and pre-clinical findings for the treatment of Non-Hodgkins Lymphoma at the 47th Annual Meeting of the American Society of Hematology, December 10-13, Atlanta, GA.
RPCI Presents Pre-clinical Research for Hematological Cancers at National Meeting: Dec-01-2005 — Eunice Wang, MD, Department of Medicine, Roswell Park Cancer Institute (RPCI), will present pre-clinical research for a novel anti-angiogenic agent for hematological cancers at the 47th Annual Meeting of the American Society of Hematology, December 10 -13, Atlanta, GA.
Heparins May Benefit Cancer Survival Research Presented at National Hematology Meeting: Dec-01-2005 — Michael K.K. Wong, MD, PhD, Department of Medicine, Roswell Park Cancer Institute, will present preliminary results of a study demonstrating how heparins act to benefit survival in cancer patients by exerting anti-angiogenic effects on tumors at the 47th Annual Meeting of the American Society of Hematology, December 10-13, Atlanta, GA.
Myron S. Czuczman, MD, to Co-Moderate Lymphoma Session at National Hematology Meeting: Dec-01-2005 — Myron S. Czuczman, MD, Chief of the Lymphoma/Myeloma Service, RPCI, will co-moderate the session titled “Lymphoma: Therapy with Biologic Agents, Excluding Pre-Clinical Models I,” at the 47th Annual Meeting of the American Society of Hematology.
Roswell Park Awarded $729,000 Grant to Study Novel Therapies for Leukemia and Lymphoma: Nov-28-2005 — The American Cancer Society (ACS) has awarded Eunice Wang, MD, departments of Medicine and Immunology at Roswell Park Cancer Institute (RPCI) a $729,000 grant to study “Antiangiogenic Mechanisms in Hematological Malignancies.”
Roswell Park Surgeons Perform 100th Prostate Cancer Robotic Surgery: Nov-28-2005 — The Minimally Invasive Surgical Center at Roswell Park Cancer Institute has treated its 100th patient with a radical prostatectomy using the da Vinci® Surgical Robotic System.
Chernobyl Study Finds No Evidence of Increased Risk of Childhood Leukemia: Nov-16-2005 — The first reported population-based study of childhood leukemia among persons exposed to radiation following the explosion of the Chernobyl Nuclear Power Plant April 26, 1986, has uncovered “no convincing evidence” of an increased risk of childhood leukem
Roswell Park Opens State-of-the-Art Minimally Invasive Surgical Center: Sep-21-2005 — RPCI has opened a newly-constructed state-of-the-art Minimally Invasive Surgery Center to bring the next generation of surgery to cancer patients and provide educational opportunities to physicians and nurses.
Roswell Park Awards American Cancer Society Grants: Sep-12-2005 — Roswell Park Cancer Institute (RPCI) has awarded two, $20,000 Institutional Research Grants (IRGs) to Eugene Yu, PhD, Department of Cancer Genetics, and Hyung Kim, MD, Department of Urologic Oncology.
Roswell Park Faculty Present at National Radiotherapy Meetings: Sep-12-2005 — Members of the Medical Physics division of the Department of Radiation Medicine recently presented research at the annual meetings of the American Association of Physicists in Medicine and the Radiotherapy Service Engineers Association.
Roswell Park Cancer Institute Offers Pastoral Care Programs: Aug-20-2005 — The Division of Pastoral Care will present two, 22-week programs for individuals who would like to update their knowledge on health care issues and pastoral care. Both programs will begin the week of September 12 at RPCI.
Novel Compound Enhances Colon Cancer Treatment: Aug-03-2005 — A team of researchers from Roswell Park Cancer Institute (RPCI) have identified a novel compound that shows promise in enhancing anti-colon cancer therapies.
Roswell Park Medical News Stories Nationally Recognized: Jul-01-2005 — The Department of Marketing, Planning and Public Affairs at Roswell Park Cancer Institute (RPCI) recently received two awards for its medical news stories from the Videographers Awards, an international awards program.
BREAKING NEWS/LOCAL ANGLE: Jun-27-2005 — A clinical trial found that the survival rate for patients with early-stage non-small cell lung cancer improved significantly when the chemotherapy regimen of vinorelbine plus cisplatin was administered following surgery.
Gilda Radner Familial Ovarian Cancer Registry Celebrates 25th Anniversary: Jun-02-2005 — The Gilda Radner Familial Ovarian Cancer Registry, established in 1981 to track families who have included at least two first degree relatives diagnosed with ovarian cancer, is celebrating its 25th anniversary.
Don't Forget to Protect Skin From the Sun: May-16-2005 — According to current estimates, up to 50 percent of Americans will have skin cancer at least once before they retire. Most skin cancer is caused by repeated exposure to ultraviolet radiation from the sun.
Leukemia Research at ASCO Annual Meeting: May-16-2005 — Meir Wetzler, MD, and colleagues will present the preliminary results of their clinical study titled, “Targeting signal transducer and activator of transcription 3 protein with arsenic trioxide – a phase I clinical trial,” (abstract # 6538) at ASCO.
Chemotherapy Research at ASCO Annual Meeting: May-14-2005 — Marwan Fakih, MD, and colleagues will present the results of their clinical study titled, “A phase I and biological correlates study of capecitabine (CAP) + oxaliplatin (OX) + radiation therapy (RT) in locally advanced rectal cancer,” (abstract #3633)
RPCI at ASCO: May-12-2005 — Faculty members from Roswell Park Cancer Institute (RPCI) will present their research at the 41st annual meeting of the American Society of Clinical Oncology
TEM at Roswell Park: Apr-11-2005 — RPCI is offering men and women diagnosed with rectal cancer another option when it comes to treating their disease aggressively. A new surgical procedure enables surgeons at RPCI to remove rectal tumors without radical surgery.
Roswell Park Offers Study to Patients with Chronic Lymphocytic Leukemia: Mar-25-2005 — Roswell Park Cancer Institute (RPCI) has initiated a study of a new drug treatment for patients with chronic lymphocytic leukemia (CLL). Asher Chanan-Khan, MD, Department of Medicine, RPCI, is the principal investigator of the study.
RPCI Physician Authors Chapter on Soft Tissue Sarcoma and Skin Cancer: Mar-04-2005 — Nathalie C. Zeitouni, MD, Department of Dermatology, RPCI today announced her participation in the development and release of a chapter titled “Soft Tissue Sarcoma and Skin Cancer” in the Surgery Review Illustrated – 2005 edition
WNY Breast Resource Center offers Seminar to Survivors: Mar-02-2005 — The WNY Breast Resource Center at RPCI, is sponsoring a bus trip to the 2nd Annual Cindy Dertinger Seminar, “Advanced Cancer, Tools for the Journey” on Friday, April 1, 2005 at the Memorial Art Gallery, 500 University Ave., Rochester, NY.
Roswell Park Study Evaluates Oral Hepatitis B Vaccine: Feb-15-2005 — An oral vaccine administered in genetically engineered potatoes shows promise against the Hepatitis B Virus (HBV) according to researchers at Roswell Park Cancer Institute ...
RPCI To Study New Treatment for Advanced Prostate Cancer: Feb-14-2005 — Roswell Park Cancer Institute (RPCI) is offering a new treatment to patients who have advanced prostate cancer to produce remission in patients with recurring cancer.
New Drug Combination May Help Advanced Multiple Myeloma: Feb-09-2005 — Patients with advanced multiple myeloma may benefit from a new combination of chemotherapy drugs. The combination of bortezomib (Velcade), liposomal doxorubicin (Doxil) and thalidomide created a clinical response in 54 percent of patients ...
Roswell Park Affiliate in Ithaca to Unveil Radiation Medicine Service: Jan-13-2005 — Cancer patients in Tompkins County and the Finger Lakes region will have access to state-of-the-art radiation therapy services as of January 17 with the opening of Cayuga Medical Center (CMC) Radiation Medicine.
Screening for Distress in Cancer Patients: Jan-11-2005 — Research published in a recent issue of Psycho-Oncology suggests that the NCCN Distress Management Screening Measure offers an efficient method for rapid screening and identification of distress experienced by cancer patients.
Roswell Park Participates in Development of Guidelines for Cancer Distress Treatment Guidelines: Jan-11-2005 — RPCI today announced its participation in the development and release of the new Distress Treatment Guidelines for Patients from the NCCN in collaboration with the ACS.